平均随访379天后,阿司匹林抵抗患者的混合事件发生率为15.6%,而无阿司匹林抵抗患者的混合事件发生率为5.3%。
After an average of 379 days, the composite outcome was documented in 15.6% of the aspirin-resistant patients compared to 5.3% of patients who were not resistant to aspirin.
平均随访379天后,阿司匹林抵抗患者的混合事件发生率为15.6%,而无阿司匹林抵抗患者的混合事件发生率为5.3%。
After an average of 379 days, the composite outcome was documented in 15.6% of the aspirin-resistant patients compared to 5.3% of patients who were not resistant to aspirin.
应用推荐